Welcome
Support Centre
14 March 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
The role of Oxidant Stress on the induction of the Inflammatory Reaction by Cardiopulmonary Bypass
ISRCTN ISRCTN76622877
ClinicalTrials.gov identifier
Public title The role of Oxidant Stress on the induction of the Inflammatory Reaction by Cardiopulmonary Bypass
Scientific title
Acronym N/A
Serial number at source N0123138565
Study hypothesis 1. To study the mechanism by which inflammatory response to cardiopulmonary bypass is modulated by oxidant stress
2. To use an ex-vivo model of cardiopulmonary bypass (CPB) and blood samples from patients to investigate oxygen free radicals on the pathogenesis
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Surgery: Cardiovascular
Participants - inclusion criteria Patients with ischaemic heart disease (IHD) scheduled for elective cardiac operations will be selected.
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 05/12/2003
Anticipated end date 30/09/2006
Status of trial Completed
Patient information material
Target number of participants Not provided at time of registration
Interventions The project is composed of laboratory based investigation and the molecular changes associated with the re-circulation of blood in an artificial surface will be studied using a surrogate model of CPB. A total of 400 patients will be randomised to one of the groups: IHD with and without Hypertension, IHD with and without Hypercholesterolemia, IHD with and without Diabetes, Healthy control.
Primary outcome measure(s) Proinflammatory cytokines, antioxidant capacity, oxygen free radicals and clinical outcomes.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding University Hospitals of Leicester NHS Trust (UK)
Trial website
Publications
Contact name Dr  B  Matata
  Address University Hospitals of Leicester
c/o Research and Development Office
Leicester General Hospital NHS Trust
  City/town Leicester
  Zip/Postcode LE1 4PW
  Country United Kingdom
Sponsor Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
  Address The Department of Health,
Richmond House,
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 30/09/2004
Last edited 15/02/2008
Date ISRCTN assigned 30/09/2004
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© ISRCTN


BioMed Central